The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) (Q57703684)
article
Language:
(P31) (Q13442814)
(P50) (Q16561003)
(P304) 328-35
(P407) (Q1860)
(P433) 4
(P478) 1
(P577) +2000-12-00T00:00:00Z
(P921) (Q410074)
(P1433) (Q6296180)
(P1476) "The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)" (language: en)
(P2093) B M Brenner
M E Cooper
D de Zeeuw
J P Grunfeld
W F Keane
K Kurokawa
J B McGill
W E Mitch
H H Parving
A B Ribeiro
M D Schluchter
D Snavely
Z Zhang
R Simpson
D Ramjit
S Shahinfar
(P2860) (Q54611974)
(Q46755654)
(Q35821338)
(Q42285869)
(Q39413560)
(Q26778425)
(Q29547873)
(Q46534931)
(Q27861088)
(Q34720231)
(Q29617736)
(Q29619460)
(Q46080832)
(Q51601011)
(Q50625243)
(Q42278661)
(Q53623646)
(Q53620961)
(Q34502430)
(Q57704237)
(Q29619542)
(Q34734009)
other details
description article

External Links